US to develop Mapp's Ebola treatment
September 02, 2014 at 15:23 PM EDT
A U.S. government agency said on Tuesday that it would accelerate the development of an Ebola treatment from Mapp Biopharmaceutical.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.